Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents

被引:179
作者
Yirmiya, R
Pollak, Y
Barak, O
Avitsur, R
Ovadia, H
Bette, M
Weihe, E
Weidenfeld, J
机构
[1] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Neurol, IL-91010 Jerusalem, Israel
[3] Univ Marburg, Dept Mol Neuroimmunol, Inst Anat & Cell Biol, Marburg, Germany
关键词
fluoxetine (Prozac); imipramine; lipopolysaccharide (LPS); tumor necrosis factor-alpha (TNF alpha); iInterleukin-1 beta (IL-1 beta); corticotrophin-releasing hormone (CRH); corticosterone; fever; depression;
D O I
10.1016/S0893-133X(00)00226-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Antidepressants produce various immunomodulatory effects, as well as an attenuation of the behavioral responses to immune challenges, such as lipopolysaccharide (LPS). To explore further the effects of antidepressants on neuroimmune interactions, rats were treated daily with either fluoxetine (Prozac) or saline for 5 weeks, and various behavioral, neuroendocrine, and immune functions were measured following administration of either LPS or saline. Chronic fluoxetine treatment significantly attenuated tire anorexia and body weight loss, ns well as the depletion of CXH-41 from the median eminence and the elevation in serum corticosterone levels induced by LPS. Chronic treatment with imipramine also attenuated LPS-induced adrenocortical activation. In vats and in mice, which normally display a biphasic body temperature response to LPS (initial hypothermia followed by hyperthermia), chronic treatment with fluoxetine completely abolished the hypothermic response and facilitated and strengthened the hyperthermic response. The effects of antidepressants on the responsiveness to LPS are probably not mediated by their effects on peripheral proinflammatory cytokine production, because LPS-induced expression of TNF alpha and IL-1 beta mRNA in the spleen (assessed by semiquantitative in situ hybridization) was not altered following chronic treatment with either fluoxetine or imipramine. The effects of antidepressants on the acute phase response may have important clinical implications for the psychiatric and neuroendocrine disturbances that are commonly associated with various medical conditions. (C) 2001 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:531 / 544
页数:14
相关论文
共 65 条
  • [1] Alexopoulos GS, 1996, J CLIN PSYCHIAT, V57, P14
  • [2] CHRONIC FLUOXETINE TREATMENT REDUCES HYPOTHALAMIC VASOPRESSIN SECRETION INVITRO
    ALTEMUS, M
    CIZZA, G
    GOLD, PW
    [J]. BRAIN RESEARCH, 1992, 593 (02) : 311 - 313
  • [3] Anisman H, 1999, ADV EXP MED BIOL, V461, P199
  • [4] EFFECTS OF CHLOMIPRAMINE AND FLUOXETINE ON SUBCUTANEOUS CARRAGEENAN-INDUCED INFLAMMATION IN THE RAT
    BIANCHI, M
    ROSSONI, G
    SACERDOTE, P
    PANERAI, AE
    BERTI, F
    [J]. INFLAMMATION RESEARCH, 1995, 44 (11) : 466 - 469
  • [5] FLUOXETINE REDUCES INFLAMMATORY EDEMA IN THE RAT - INVOLVEMENT OF THE PITUITARY-ADRENAL AXIS
    BIANCHI, M
    SACERDOTE, P
    PANERAI, AE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (1-2) : 81 - 84
  • [6] BLUTHE RM, 1992, ANN NY ACAD SCI, V650, P268
  • [7] THE ANTIDEPRESSANTS FLUOXETINE, IDAZOXAN AND PHENELZINE ALTER CORTICOTROPIN-RELEASING HORMONE AND TYROSINE-HYDROXYLASE MESSENGER-RNA LEVELS IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS
    BRADY, LS
    GOLD, PW
    HERKENHAM, M
    LYNN, AB
    WHITFIELD, HJ
    [J]. BRAIN RESEARCH, 1992, 572 (1-2) : 117 - 125
  • [8] LONG-TERM ANTIDEPRESSANT ADMINISTRATION ALTERS CORTICOTROPIN-RELEASING HORMONE, TYROSINE-HYDROXYLASE, AND MINERALOCORTICOID RECEPTOR GENE-EXPRESSION IN RAT-BRAIN - THERAPEUTIC IMPLICATIONS
    BRADY, LS
    WHITFIELD, HJ
    FOX, RJ
    GOLD, PW
    HERKENHAM, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 831 - 837
  • [9] CHAPPELL PB, 1986, J NEUROSCI, V6, P2908
  • [10] Cytokines and depression: fortuitous or causative association?
    Dantzer, R
    Wollman, E
    Vitkovic, L
    Yirmiya, R
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 (04) : 328 - 332